Has Nicole Pickett received payments from drug or device companies?

Yes. Drug and device makers reported $2,598 in general payments to Nicole Pickett across 129 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Nicole Pickett did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Nicole Pickett come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Nicole Pickett

Family · Newnan, GANPI 1477076370

Payments from drug & device makers

$2,598in general payments, 2019–2025

Across 129 payments — averaging $20.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$532
Johnson & Johnson$312
Takeda Pharmaceuticals U.S.A., Inc.$300
Ipsen Biopharmaceuticals, Inc$266
Sanofi$144
Ardelyx, Inc.$142
plus $903 from 16 others

What the payments were for

Food & beverage$2,54498%
Education$542%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	34	$532
Johnson & Johnson	14	$312
Takeda Pharmaceuticals U.S.A., Inc.	15	$300
Ipsen Biopharmaceuticals, Inc	9	$266
Sanofi	5	$144
Ardelyx, Inc.	7	$142
Regeneron Healthcare Solutions, Inc.	6	$140
Madrigal Pharmaceuticals	4	$118
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	6	$115
Lilly USA, LLC	5	$105
Phathom Pharmaceuticals, Inc.	6	$85
Pfizer	4	$72
Intercept Pharmaceuticals, Inc.	3	$55
QOL Medical, LLC	2	$47
Organon	2	$37
Axonics, Inc.	1	$26
Bristol Myers Squibb	1	$22
Merck	1	$19
Fresenius Kabi USA, LLC	1	$17
Ironwood Pharmaceuticals, Inc	1	$17
Braintree Laboratories, Inc.	1	$15
Mauna Kea Technologies, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

IQIRVO$134

How this compares

$2,598 in reported general payments places this provider in the 80th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
LinzessLinaclotide	19	$27,718
Mesalamine	12	$11,675
Sucralfate	143	$11,241
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates	152	$9,852
Colesevelam Hcl	34	$7,442
Pantoprazole Sodium	328	$4,398
Omeprazole	331	$3,915
Ondansetron OdtOndansetron	58	$1,467
CholestyramineCholestyramine (With Sugar)	14	$1,281
Budesonide DrBudesonide	12	$1,158
Famotidine	89	$1,158
Dicyclomine Hcl	15	$490
Hydrocortisone	71	$462
Esomeprazole Magnesium	14	$410
Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl	17	$282

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
AbbVieLinzess	$532	$27,71819 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 6,258 family providers in Georgia.

Other family in Newnan

Allie McAllisterMarietta$299K
Tonita WashingtonLawrenceville$153K
Erin HenryLawrenceville$135K
Trisha RomanPeachtree City$134K
Lori ReedMarietta$106K
Julia BranchCumming$102K
Hannah BanachWaycross$85K
Morgan GroothandEvans$81K
Anna Carolina WrightLilburn$69K
Jessica FeehanCanton$51K

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →